T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
General Mills
GIS
$20.8B
| $59.2M | 0.01% |
785,016
-85,286
| -10% | -$5.97M |
|
|
GBIO
827
DELISTED
Generation Bio
GBIO
| $58.6M | 0.01% |
893,161
+16,792
| +2% | +$1.1M |
|
828
Nurix Therapeutics
NRIX
$2.82B
| $58.5M | 0.01% |
4,620,823
-185,466
| -4% | -$2.1M |
|
829
Medpace
MEDP
$16.2B
| $58.3M | 0.01% |
389,589
-88,337
| -18% | -$12.8M |
|
830
Visteon
VC
$2.86B
| $58M | 0.01% |
559,681
-8,158
| -1% | -$842K |
|
831
ON Semiconductor
ON
$31.8B
| $57.7M | 0.01% |
1,146,453
+363,048
| +46% | +$20.2M |
|
832
Archer Daniels Midland
ADM
$38.6B
| $57.5M | 0.01% |
741,382
-67,843
| -8% | -$5.93M |
|
833
Parker-Hannifin
PH
$134B
| $57.5M | 0.01% |
233,747
-706,606
| -75% | -$189M |
|
834
Ford
F
$55.4B
| $57.5M | 0.01% |
5,166,599
-512,232
| -9% | -$7.01M |
|
835
Boston Omaha
BOC
$431M
| $57.4M | 0.01% |
2,781,654
+315
| +0% | +$6.9K |
|
836
Graphic Packaging
GPK
$3.51B
| $56.7M | 0.01% |
2,765,759
+2,498,874
| +936% | +$52.8M |
|
837
Agios Pharmaceuticals
AGIO
$2B
| $56.5M | 0.01% |
2,546,986
-154,639
| -6% | -$3.49M |
|
838
Pennant Group
PNTG
$1.35B
| $56M | 0.01% |
4,370,782
+143,803
| +3% | +$2.39M |
|
839
Capitol Federal Financial
CFFN
$1.09B
| $55.7M | 0.01% |
6,070,938
-2,625,112
| -30% | -$25.9M |
|
840
Omnicell
OMCL
$1.72B
| $55.7M | 0.01% |
489,752
-33,741
| -6% | -$3.87M |
|
841
Murphy USA
MUSA
$10.4B
| $55.5M | 0.01% |
238,500
+22,704
| +11% | +$5.35M |
|
|
HNGR
842
DELISTED
Hanger Inc.
HNGR
| $55.5M | 0.01% |
3,872,701
-259,926
| -6% | -$4.22M |
|
843
Builders FirstSource
BLDR
$7.91B
| $55.2M | 0.01% |
1,028,634
-10,399
| -1% | -$638K |
|
844
Insperity
NSP
$2.05B
| $55.1M | 0.01% |
552,188
+10,299
| +2% | +$1.02M |
|
845
Brink's
BCO
$4.72B
| $55M | 0.01% |
906,060
-4,215
| -0.5% | -$254K |
|
846
Targa Resources
TRGP
$57.2B
| $55M | 0.01% |
921,440
-45,315
| -5% | -$3.25M |
|
847
Ameriprise Financial
AMP
$50.4B
| $54.8M | 0.01% |
230,633
+12,262
| +6% | +$3.28M |
|
848
Emcor
EME
$36.7B
| $54.8M | 0.01% |
531,981
-59,156
| -10% | -$6.32M |
|
849
Healthcare Realty
HR
$6.58B
| $54.2M | 0.01% |
1,940,812
+146,372
| +8% | +$4.35M |
|
850
Blue Owl Capital
OWL
$19.7B
| $53.8M | 0.01% |
5,366,944
+5,298,444
| +7,735% | +$63.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.